Morgan E. Obrien - Dec 2, 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
/s/ Gena Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
4
Date filed
12/6/2022, 05:36 PM
Previous filing
Aug 10, 2022
Next filing
Mar 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +154K $0.00 154K Dec 2, 2022 Common Stock 154K $49.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the option shares vest and become exercisable on December 2, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.